Sleep Wake Transition

>

Latest News

The treatment significantly reduced the frequency of cataplexy attacks in patients with narcolepsy compared with placebo.
Phase 3 Trial of AXS-12 for Narcolepsy Meets Primary Endpoint

March 26th 2024

The treatment significantly reduced the frequency of cataplexy attacks in patients with narcolepsy compared with placebo.

Researchers investigated the prevalence and correlates of sleep disorders in patients with first-episode psychosis.
Prevalence and Correlates of Sleep Disorders in First-Episode Psychosis

August 28th 2023

From adherence in addiction recovery treatment to the relationship between social media use and youth mental health, here are highlights from the week in Psychiatric Times.
The Week in Review: June 5-9

June 10th 2023

Although more than 90% of children had at least 1 caregiver-reported sleep problem, only 20% had a clinician-documented sleep problem.
Study Explores Discrepancies Between Caregiver, Clinician Reports of Sleep Problems in Children

June 8th 2023

Researchers investigated sleep disturbances in individuals at ultra-high risk of psychosis.
Sleep Disturbances in Individuals at Ultra-High Risk of Psychosis

March 16th 2023

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.